Syracuse Biolabs, Inc.

Camillus, NY

UEI
QAW2G2NJY562
CAGE
7BEU5
Primary NAICS
541713 Research and Development in Nanotechnology
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Subchapter S Corporation
Entity structure
Corporate Entity (Not Tax Exempt)
Other NAICS codes in SAM.gov
SAM.gov registration date
Physical address
142 Park Way, Camillus, NY 13031, USA
Website
syrbiolabs.com
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Commercialization of a phylogenetic cell separation method for downstream purification of nucleic acids R42GM140530 National Institute of General Medical Sciences (NIH) $1,556,002
A novel method for improved separation of metagenomic samples for preservation and identification. R41GM140530 National Institute of General Medical Sciences (NIH) $656,538

Quick answers

Is Syracuse Biolabs, Inc. registered in SAM.gov?

Yes. Syracuse Biolabs, Inc.'s SAM.gov registration is active through January 7, 2027.

What is Syracuse Biolabs, Inc.'s most recent federal award?

Syracuse Biolabs, Inc.'s most recent federal grant award is Commercialization of a phylogenetic cell separation method for downstream purification of nucleic acids (R42GM140530), from National Institute of General Medical Sciences (NIH), on September 15, 2021.

On GovTribe

See Syracuse Biolabs, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login